ABEO stock

Abeona Therapeutics Inc (ABEO) financials · rev $20.1M

Abeona Therapeutics Inc (ABEO) rev $20.1M.

Cached annual income statement
LineFY2025FY2024
Revenue$5.8M$4.2M
Cost of Revenue$1.5M$0
Gross Profit$4.3M$0
Operating Income-$89.4M-$64.2M
Net Income$71.2M-$63.7M
EPS (Diluted)$1.01$-1.55
Cached annual balance sheet
LineFY2025FY2024
Total Assets$219.6M$108.9M
Current Assets$204.9M$100.9M
Cash & Equivalents$78.4M$23.4M
Inventory$5.5M$0
PP&E$9.9M$4.4M
Total Liabilities$60.4M$64.9M
Current Liabilities$29.6M$16.6M
Short-term Debt$12.2M$5.9M
Long-term Debt$7.8M$13.0M
Total Debt$0$0
Shareholders' Equity$159.2M$44.0M
Retained Earnings-$742.1M-$813.3M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$76.3M-$56.0M
CapEx$8.0M$2.4M
Investing Cash Flow$105.0M-$39.2M
Financing Cash Flow$26.0M$104.1M
Dividends Paid$0$0
Net Change in Cash$54.7M$8.9M
Free Cash Flow-$84.3M-$58.5M

FAQ

What is ABEO P/E and revenue?

Abeona Therapeutics Inc (ABEO) rev $20.1M.

What is ABEO revenue?

Abeona Therapeutics Inc last cached revenue is $5.8M (FY2025).

Is ABEO profitable?

Abeona Therapeutics Inc last cached net income is $71.2M.

What are ABEO total assets?

Abeona Therapeutics Inc last cached total assets are $219.6M.

What is ABEO free cash flow?

Abeona Therapeutics Inc last cached free cash flow is -$84.3M.

Not investment advice. Cached statements, not a live tape.